Cargando…

Primary midbrain germinoma relapse-free for 5 years: A case report

BACKGROUND: The biology and clinical course of intracranial germinomas differ as per their location of occurrence. Germinoma of the primary midbrain is particularly rare, and its clinical features, treatment strategies, and long-term prognosis remain uncertain. CASE DESCRIPTION: A 39-year-old man wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Akito, Kimura, Toshikazu, Akabane, Atsuya, Inoue, Tomohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805627/
https://www.ncbi.nlm.nih.gov/pubmed/36600775
http://dx.doi.org/10.25259/SNI_703_2022
Descripción
Sumario:BACKGROUND: The biology and clinical course of intracranial germinomas differ as per their location of occurrence. Germinoma of the primary midbrain is particularly rare, and its clinical features, treatment strategies, and long-term prognosis remain uncertain. CASE DESCRIPTION: A 39-year-old man who had been diagnosed with midbrain germinoma by open biopsy through the occipital transtentorial approach had undergone chemoradiotherapy and achieved 5 years with no recurrence. CONCLUSION: Germinomas should be considered as a differential diagnosis for adolescents and young adult men with mesencephalic tumors, and reliable sampling followed by chemoradiotherapy must be performed.